President Donald Trump on Thursday struck landmark deals with Eli Lilly and Novo Nordisk that could mark a turning point in how many people can access their costly blockbuster obesity …
Eli Lilly and Co
-
-
Wall Street Struggles: Nasdaq and S&P 500 End Winning Streaks November started poorly on Wall Street. The tech-focused Nasdaq dropped over 3%, marking its worst week since early April. The …
-
A combination image shows an injection pen of Zepbound, eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters Teh appetite for blockbuster …
-
stock Futures Edge Lower After Regional Bank Concerns Trigger Sell-Off Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October 16, 2025. …
-
Shutdown Doesn’t Phase Market as Stocks Hit Records Day three of the federal government shutdown came and went Friday, with no end in sight. Despite this, the stock market continued …
-
HereS a list of the pharmaceutical companies mentioned in the text: Novartis (NVS) Novo Nordisk (NVO) Pfizer (PFE) Regeneron (REGN) * Sanofi (SNY) “`html Trump Demands 60-day Drug Price Cuts: …